Al-Qahtani Ahmed A, Abdel-Muhsin Abdel-Muhsin A, Dajem Saad M Bin, AlSheikh Adel Ali H, Bohol Marie Fe F, Al-Ahdal Mohammed N, Putaporntip Chaturong, Jongwutiwes Somchai
Department of Infection and Immunity, King Faisal Specialist Hospital & Research Center, Riyadh 11211, Saudi Arabia; Department of Microbiology and Immunology, Alfaisal University College of Medicine, Riyadh, Saudi Arabia.
Tropical Medicine Research Institute, National Centre for Research, Sudan; Department of Biology, Faculty of Science, University of Hail, Hail, Saudi Arabia.
Infect Genet Evol. 2016 Apr;39:381-388. doi: 10.1016/j.meegid.2016.02.010. Epub 2016 Feb 8.
The apical membrane antigen 1 of Plasmodium falciparum (PfAMA1) plays a crucial role in erythrocyte invasion and is a target of protective antibodies. Although domain I of PfAMA1 has been considered a promising vaccine component, extensive sequence diversity in this domain could compromise an effective vaccine design. To explore the extent of sequence diversity in domain I of PfAMA1, P. falciparum-infected blood samples from Saudi Arabia collected between 2007 and 2009 were analyzed and compared with those from worldwide parasite populations. Forty-six haplotypes and a novel codon change (M190V) were found among Saudi Arabian isolates. The haplotype diversity (0.948±0.004) and nucleotide diversity (0.0191±0.0008) were comparable to those from African hyperendemic countries. Positive selection in domain I of PfAMA1 among Saudi Arabian parasite population was observed because nonsynonymous nucleotide substitutions per nonsynonymous site (dN) significantly exceeded synonymous nucleotide substitutions per synonymous site (dS) and Tajima's D and its related statistics significantly deviated from neutrality in the positive direction. Despite a relatively low prevalence of malaria in Saudi Arabia, a minimum of 17 recombination events occurred in domain I. Genetic differentiation was significant between P. falciparum in Saudi Arabia and parasites from other geographic origins. Several shared or closely related haplotypes were found among parasites from different geographic areas, suggesting that vaccine derived from multiple shared epitopes could be effective across endemic countries.
恶性疟原虫顶端膜抗原1(PfAMA1)在红细胞入侵过程中起关键作用,是保护性抗体的作用靶点。尽管PfAMA1的结构域I被认为是一种很有前景的疫苗成分,但该结构域广泛的序列多样性可能会影响有效的疫苗设计。为了探究PfAMA1结构域I的序列多样性程度,对2007年至2009年期间从沙特阿拉伯采集的恶性疟原虫感染血液样本进行了分析,并与来自全球寄生虫群体的样本进行了比较。在沙特阿拉伯分离株中发现了46种单倍型和一个新的密码子变化(M190V)。单倍型多样性(0.948±0.004)和核苷酸多样性(0.0191±0.0008)与非洲高流行国家的情况相当。在沙特阿拉伯寄生虫群体中观察到PfAMA1结构域I存在正选择,因为非同义位点的非同义核苷酸替换(dN)显著超过同义位点的同义核苷酸替换(dS),并且Tajima's D及其相关统计量明显偏离中性向正向发展。尽管沙特阿拉伯的疟疾流行率相对较低,但结构域I至少发生了17次重组事件。沙特阿拉伯的恶性疟原虫与其他地理来源的寄生虫之间存在显著的遗传分化。在来自不同地理区域的寄生虫中发现了几种共享或密切相关的单倍型,这表明源自多个共享表位的疫苗可能在各流行国家都有效。